New funding opportunity is now closed
Our ambition is to stop prostate cancer from killing thousands of men each year. Every man diagnosed with the disease should receive the most effective treatment for their cancer. To achieve this, we need to add new treatment options to our arsenal, and to be smarter with how and when we use these therapies to achieve maximum effect.
On 7 May 2019 we launched a funding call for proposals to investigate the immunology of prostate cancer, providing the framework for new immunotherapeutic approaches for treating prostate cancer. The specific remit for this call is detailed in the corresponding guidance notes.
The submission deadline was 12pm noon Monday 22 July 2019.